Efficacy and safety of dexamethasone nanoparticles eye drops in diabetic macular edema.
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2018
At a glance
- Drugs Dexamethasone (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Sponsors Oculis Pharma
- 09 May 2018 Planned End Date changed from 5 May 2018 to 9 Jan 2019.
- 09 May 2018 Planned number of patients changed from 96 to 144.
- 18 Jul 2017 New trial record